PMC:7170415 / 27742-28332 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"374","span":{"begin":533,"end":544},"obj":"Species"},{"id":"375","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A374","pred":"tao:has_database_id","subj":"374","obj":"Tax:12814"},{"id":"A375","pred":"tao:has_database_id","subj":"375","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) ."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T107","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"mondo_id","subj":"T107","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) ."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T242","span":{"begin":153,"end":160},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T243","span":{"begin":304,"end":311},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T244","span":{"begin":448,"end":455},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T245","span":{"begin":487,"end":488},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T246","span":{"begin":545,"end":552},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) ."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43","span":{"begin":99,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A43","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"}],"text":"Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) ."}

{"project":"LitCovid-sentences","denotations":[{"id":"T190","span":{"begin":0,"end":161},"obj":"Sentence"},{"id":"T191","span":{"begin":162,"end":590},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Initially, the need for elaborate biosafety precautions and inconsistent recommendations for their application across regions severely hampered COVID-19 testing. Although these continue to evolve, current recommendations in Canada and the United States acknowledge that nonpropagative work for molecular testing may be performed in containment level 2 conditions found in routine diagnostic laboratories and provide specific guidance on diagnostic testing of specimens conducted outside a biosafety level 2 laboratory, such as rapid respiratory testing performed at the point of care (67) ."}